Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve

References

• Alexandru, P., Cekic, S., Yildiz, S., Turkgeldi, E., & Ata, B. (2020). Progestins vs gonadotropin releasing hormone analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology, a systematic review and meta-analysis. Reproductive BioMedicine Online, 40(6), 894–903. https://doi.org/https://doi.org/10.1016/j.rbmo.2020.01.027
   PubMed Web of Science ®Google Scholar
• Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane Database of Systematic Reviews, 4, CD001750. https://doi.org/https://doi.org/10.1002/14651858.CD001750.pub4
   PubMedGoogle Scholar
• Begueria, R., Garcia, D., Vassena, R., & Rodriguez, A. (2019). Medroxyprogesterone acetate versus ganirelix in oocyte donation: A randomized controlled trial. Human Reproduction, 34(5), 872–880. https://doi.org/https://doi.org/10.1093/humrep/dez034
   PubMed Web of Science ®Google Scholar
• Chen, Q., Wang, Y., Sun, L., Zhang, S., Chai, W., Hong, Q., Long, H., Wang, L., Lyu, Q., & Kuang, Y. (2017). Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reproductive Biology and Endocrinology, 15(1), 71. https://doi.org/https://doi.org/10.1186/s12958-017-0291-0
   PubMedGoogle Scholar
• Chen, Y. M., Qi, Q. R., Xie, Q. Z., Yang, Y. F., Xia, Y., & Zhou, X. D. (2018). Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF/ICSI cycle: A self-controlled study. Current Medical Science, 38(3), 513–518. https://doi.org/https://doi.org/10.1007/s11596-018-1908-z
   PubMed Web of Science ®Google Scholar
• Cimadomo, D., Vaiarelli, A., Colamaria, S., Trabucco, E., Alviggi, C., Venturella, R., Alviggi, E., Carmelo, R., Rienzi, L., & Ubaldi, F. M. (2018). Luteal phase anovulatory follicles result in the production of competent oocytes: Intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle. Human Reproduction, 33(8), 1442–1448. https://doi.org/https://doi.org/10.1093/humrep/dey217
   PubMed Web of Science ®Google Scholar
• Dong, J., Wang, Y., Chai, W. R., Hong, Q. Q., Wang, N. L., Sun, L. H., Long, H., Wang, L., Tian, H., Lyu, Q. F., Lu, X. F., Chen, Q. J., & Kuang, Y. P. (2017). The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: A randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 124(7), 1048–1055. https://doi.org/https://doi.org/10.1111/1471-0528.14622
   PubMed Web of Science ®Google Scholar
• Donnez, J., & Dolmans, M. M. (2013). Fertility preservation in women. Nature Reviews Endocrinology, 9(12), 735–749. https://doi.org/https://doi.org/10.1038/nrendo.2013.205
   PubMed Web of Science ®Google Scholar
• Donnez, J., & Dolmans, M.-M. (2017). Fertility preservation in women. The New England Journal of Medicine, 377(17), 1657–1665. https://doi.org/https://doi.org/10.1056/NEJMra1614676
   PubMed Web of Science ®Google Scholar
• Evans, M. B., Parikh, T., DeCherney, A. H., Csokmay, J. M., Healy, M. W., & Hill, M. J. (2019). Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles. Reproductive Biomedicine Online, 38(5), 691–698. https://doi.org/https://doi.org/10.1016/j.rbmo.2018.12.044
   PubMed Web of Science ®Google Scholar
• Ferraretti, A. P., La Marca, A., Fauser, B. C. J. M., Tarlatzis, B., Nargund, G., & Gianaroli, L. (2011). ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: The Bologna criteria. Human Reproduction, 26(7), 1616–1624. https://doi.org/https://doi.org/10.1093/humrep/der092
   PubMed Web of Science ®Google Scholar
• Guo, Y.-C., Chen, P.-Y., Li, T.-T., Jia, L., Sun, P., Zhu, W.-S., Deng, C. C., Fang, C., & Liang, X.-Y. (2019). Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: An analysis of 1188 cycles. Archives of Gynecology and Obstetrics, 299(4), 1201–1212. https://doi.org/https://doi.org/10.1007/s00404-019-05065-4
   PubMed Web of Science ®Google Scholar
• Kuang, Y., Chen, Q., Fu, Y., Wang, Y., Hong, Q., Lyu, Q., Ai, A., & Shoham, Z. (2015). Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertility and Sterility, 104(1), 62–70. https://doi.org/https://doi.org/10.1016/j.fertnstert.2015.03.022
   PubMed Web of Science ®Google Scholar
• Kuang, Y., Chen, Q., Hong, Q., Lyu, Q., Ai, A., Fu, Y., & Shoham, Z. (2014). Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reproductive Biomedicine Online, 29(6), 684–691. https://doi.org/https://doi.org/10.1016/j.rbmo.2014.08.009
   PubMed Web of Science ®Google Scholar
• Kuang, Y., Hong, Q., Chen, Q., Lyu, Q., Ai, A., Fu, Y., & Shoham, Z. (2014). Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertility and Sterility, 101(1), 105–111. https://doi.org/https://doi.org/10.1016/j.fertnstert.2013.09.007
   PubMed Web of Science ®Google Scholar
• Reichman, D. E., Zakarin, L., Chao, K., Meyer, L., Davis, O. K., & Rosenwaks, Z. (2014). Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles. Fertility and Sterility, 102(1), 99–102. https://doi.org/https://doi.org/10.1016/j.fertnstert.2014.04.010
   PubMed Web of Science ®Google Scholar
• Rienzi, L., Gracia, C., Maggiulli, R., LaBarbera, A. R., Kaser, D. J., Ubaldi, F. M., Vanderpoel, S., & Racowsky, C. (2017). Oocyte, embryo and blastocyst cryopreservation in ART: Systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Human Reproduction Update, 23(2), 139–155. https://doi.org/https://doi.org/10.1093/humupd/dmw038
   PubMed Web of Science ®Google Scholar
• Roos, J., Johnson, S., Weddell, S., Godehardt, E., Schiffner, J., Freundl, G., & Gnoth, C. (2015). Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation. The European Journal of Contraception & Reproductive Health Care: The Official Journal of the European Society of Contraception, 20(6), 438–450. https://doi.org/https://doi.org/10.3109/13625187.2015.1048331
   PubMed Web of Science ®Google Scholar
• Ubaldi, F. M., Capalbo, A., Vaiarelli, A., Cimadomo, D., Colamaria, S., Alviggi, C., Trabucco, E., Venturella, R., Vajta, G., & Rienzi, L. (2016). Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: New insight in ovarian reserve exploitation. Fertility and Sterility, 105(6), 1488–1495. https://doi.org/https://doi.org/10.1016/j.fertnstert.2016.03.002
   PubMed Web of Science ®Google Scholar
• Wang, Y., Chen, Q., Wang, N., Chen, H., Lyu, Q., & Kuang, Y. (2016). Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: A double-blind randomized crossover clinical trial. Medicine, 95(9), e2939. https://doi.org/https://doi.org/10.1097/MD.0000000000002939
   PubMed Web of Science ®Google Scholar
• Yildiz, S., Turkgeldi, E., Angun, B., Eraslan, A., Urman, B., & Ata, B. (2019). Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology. Fertility and Sterility, 112(4), 677–683. https://doi.org/https://doi.org/10.1016/j.fertnstert.2019.06.009
   PubMed Web of Science ®Google Scholar
• Younis, J. S., Haddad, S., Matilsky, M., & Ben-Ami, M. (1998). Premature luteinization: Could it be an early manifestation of low ovarian reserve? Fertility and Sterility, 69(3), 461–465. https://doi.org/https://doi.org/10.1016/s0015-0282(97)00561-x
   PubMed Web of Science ®Google Scholar
• Yu, S., Long, H., Chang, H. Y-n., Liu, Y., Gao, H., Zhu, J., Quan, X., Lyu, Q., Kuang, Y., & Ai, A. (2018). New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: A randomized controlled trial including 516 first IVF/ICSI cycles. Human Reproduction, 33(2), 229–237. https://doi.org/https://doi.org/10.1093/humrep/dex367
   PubMed Web of Science ®Google Scholar
• Zhu, X., Ye, H., & Fu, Y. (2016). The utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments. Medicine, 95(28), e4193. https://doi.org/https://doi.org/10.1097/MD.0000000000004193
   PubMed Web of Science ®Google Scholar
• Zhu, X., Ye, H., & Fu, Y. (2017a). Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation. Fertility and Sterility, 108(3), 505–512. https://doi.org/https://doi.org/10.1016/j.fertnstert.2017.06.017
   PubMed Web of Science ®Google Scholar
• Zhu, X., Ye, H., & Fu, Y. (2017b). Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a “freeze all” strategy: A randomized controlled dose-finding study of 100 mg versus 200 mg. Fertility and Sterility, 107(2), 379–386. https://doi.org/https://doi.org/10.1016/j.fertnstert.2016.10.030
   PubMed Web of Science ®Google Scholar